Cargando…

Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial

BACKGROUND: Endothelial dysfunction has been proposed as the underlying cause of diabetic angiopathy that eventually leads to cardiovascular disease, the major cause of death in diabetes. We recently demonstrated the ameliorating effect of regular vitamin D intake on the glycemic status of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Shab-Bidar, Sakineh, Neyestani, Tirang R, Djazayery, Abolghassem, Eshraghian, Mohammad-Reza, Houshiarrad, Anahita, Gharavi, A'azam, Kalayi, Ali, Shariatzadeh, Nastaran, Zahedirad, Malihe, Khalaji, Niloufar, Haidari, Homa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239240/
https://www.ncbi.nlm.nih.gov/pubmed/22114787
http://dx.doi.org/10.1186/1741-7015-9-125
_version_ 1782219149292863488
author Shab-Bidar, Sakineh
Neyestani, Tirang R
Djazayery, Abolghassem
Eshraghian, Mohammad-Reza
Houshiarrad, Anahita
Gharavi, A'azam
Kalayi, Ali
Shariatzadeh, Nastaran
Zahedirad, Malihe
Khalaji, Niloufar
Haidari, Homa
author_facet Shab-Bidar, Sakineh
Neyestani, Tirang R
Djazayery, Abolghassem
Eshraghian, Mohammad-Reza
Houshiarrad, Anahita
Gharavi, A'azam
Kalayi, Ali
Shariatzadeh, Nastaran
Zahedirad, Malihe
Khalaji, Niloufar
Haidari, Homa
author_sort Shab-Bidar, Sakineh
collection PubMed
description BACKGROUND: Endothelial dysfunction has been proposed as the underlying cause of diabetic angiopathy that eventually leads to cardiovascular disease, the major cause of death in diabetes. We recently demonstrated the ameliorating effect of regular vitamin D intake on the glycemic status of patients with type 2 diabetes (T2D). In this study, the effects of improvement of vitamin D status on glycemic status, lipid profile and endothelial biomarkers in T2D subjects were investigated. METHODS: Subjects with T2D were randomly allocated to one of the two groups to receive either plain yogurt drink (PYD; containing 170 mg calcium and no vitamin D/250 mL, n(1 )= 50) or vitamin D3-fortified yogurt drink (FYD; containing 170 mg calcium and 500 IU/250 mL, n(2 )= 50) twice a day for 12 weeks. Anthropometric measures, glycemic status, lipid profile, body fat mass (FM) and endothelial biomarkers including serum endothelin-1, E-selectin and matrix metalloproteinase (MMP)-9 were evaluated at the beginning and after the 12-week intervention period. RESULTS: The intervention resulted in a significant improvement in fasting glucose, the Quantitative Insulin Check Index (QUICKI), glycated hemoglobin (HbA1c), triacylglycerols, high-density lipoprotein cholesterol (HDL-C), endothelin-1, E-selectin and MMP-9 in FYD compared to PYD (P < 0.05, for all). Interestingly, difference in changes of endothelin-1, E-selectin and MMP-9 concentrations in FYD compared to PYD (-0.35 ± 0.63 versus -0.03 ± 0.55, P = 0.028; -3.8 ± 7.3 versus 0.95 ± 8.3, P = 0.003 and -2.3 ± 3.7 versus 0.44 ± 7.1 ng/mL, respectively, P < 0.05 for all), even after controlling for changes of QUICKI, FM and waist circumference, remained significant for endothelin-1 and MMP-9 (P = 0.009 and P = 0.005, respectively) but disappeared for E-selectin (P = 0.092). On the contrary, after controlling for serum 25(OH)D, the differences disappeared for endothelin-1(P = 0.066) and MMP-9 (P = 0.277) but still remained significant for E-selectin (P = 0.011). CONCLUSIONS: Ameliorated vitamin D status was accompanied by improved glycemic status, lipid profile and endothelial biomarkers in T2D subjects. Our findings suggest both direct and indirect ameliorating effects of vitamin D on the endothelial biomarkers. TRIAL REGISTRATION: ClinicalTrials.gov: NCT01236846
format Online
Article
Text
id pubmed-3239240
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32392402012-05-03 Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial Shab-Bidar, Sakineh Neyestani, Tirang R Djazayery, Abolghassem Eshraghian, Mohammad-Reza Houshiarrad, Anahita Gharavi, A'azam Kalayi, Ali Shariatzadeh, Nastaran Zahedirad, Malihe Khalaji, Niloufar Haidari, Homa BMC Med Research Article BACKGROUND: Endothelial dysfunction has been proposed as the underlying cause of diabetic angiopathy that eventually leads to cardiovascular disease, the major cause of death in diabetes. We recently demonstrated the ameliorating effect of regular vitamin D intake on the glycemic status of patients with type 2 diabetes (T2D). In this study, the effects of improvement of vitamin D status on glycemic status, lipid profile and endothelial biomarkers in T2D subjects were investigated. METHODS: Subjects with T2D were randomly allocated to one of the two groups to receive either plain yogurt drink (PYD; containing 170 mg calcium and no vitamin D/250 mL, n(1 )= 50) or vitamin D3-fortified yogurt drink (FYD; containing 170 mg calcium and 500 IU/250 mL, n(2 )= 50) twice a day for 12 weeks. Anthropometric measures, glycemic status, lipid profile, body fat mass (FM) and endothelial biomarkers including serum endothelin-1, E-selectin and matrix metalloproteinase (MMP)-9 were evaluated at the beginning and after the 12-week intervention period. RESULTS: The intervention resulted in a significant improvement in fasting glucose, the Quantitative Insulin Check Index (QUICKI), glycated hemoglobin (HbA1c), triacylglycerols, high-density lipoprotein cholesterol (HDL-C), endothelin-1, E-selectin and MMP-9 in FYD compared to PYD (P < 0.05, for all). Interestingly, difference in changes of endothelin-1, E-selectin and MMP-9 concentrations in FYD compared to PYD (-0.35 ± 0.63 versus -0.03 ± 0.55, P = 0.028; -3.8 ± 7.3 versus 0.95 ± 8.3, P = 0.003 and -2.3 ± 3.7 versus 0.44 ± 7.1 ng/mL, respectively, P < 0.05 for all), even after controlling for changes of QUICKI, FM and waist circumference, remained significant for endothelin-1 and MMP-9 (P = 0.009 and P = 0.005, respectively) but disappeared for E-selectin (P = 0.092). On the contrary, after controlling for serum 25(OH)D, the differences disappeared for endothelin-1(P = 0.066) and MMP-9 (P = 0.277) but still remained significant for E-selectin (P = 0.011). CONCLUSIONS: Ameliorated vitamin D status was accompanied by improved glycemic status, lipid profile and endothelial biomarkers in T2D subjects. Our findings suggest both direct and indirect ameliorating effects of vitamin D on the endothelial biomarkers. TRIAL REGISTRATION: ClinicalTrials.gov: NCT01236846 BioMed Central 2011-11-24 /pmc/articles/PMC3239240/ /pubmed/22114787 http://dx.doi.org/10.1186/1741-7015-9-125 Text en Copyright ©2011 Shab-Bidar et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Shab-Bidar, Sakineh
Neyestani, Tirang R
Djazayery, Abolghassem
Eshraghian, Mohammad-Reza
Houshiarrad, Anahita
Gharavi, A'azam
Kalayi, Ali
Shariatzadeh, Nastaran
Zahedirad, Malihe
Khalaji, Niloufar
Haidari, Homa
Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial
title Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial
title_full Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial
title_fullStr Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial
title_full_unstemmed Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial
title_short Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial
title_sort regular consumption of vitamin d-fortified yogurt drink (doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239240/
https://www.ncbi.nlm.nih.gov/pubmed/22114787
http://dx.doi.org/10.1186/1741-7015-9-125
work_keys_str_mv AT shabbidarsakineh regularconsumptionofvitamindfortifiedyogurtdrinkdooghimprovedendothelialbiomarkersinsubjectswithtype2diabetesarandomizeddoubleblindclinicaltrial
AT neyestanitirangr regularconsumptionofvitamindfortifiedyogurtdrinkdooghimprovedendothelialbiomarkersinsubjectswithtype2diabetesarandomizeddoubleblindclinicaltrial
AT djazayeryabolghassem regularconsumptionofvitamindfortifiedyogurtdrinkdooghimprovedendothelialbiomarkersinsubjectswithtype2diabetesarandomizeddoubleblindclinicaltrial
AT eshraghianmohammadreza regularconsumptionofvitamindfortifiedyogurtdrinkdooghimprovedendothelialbiomarkersinsubjectswithtype2diabetesarandomizeddoubleblindclinicaltrial
AT houshiarradanahita regularconsumptionofvitamindfortifiedyogurtdrinkdooghimprovedendothelialbiomarkersinsubjectswithtype2diabetesarandomizeddoubleblindclinicaltrial
AT gharaviaazam regularconsumptionofvitamindfortifiedyogurtdrinkdooghimprovedendothelialbiomarkersinsubjectswithtype2diabetesarandomizeddoubleblindclinicaltrial
AT kalayiali regularconsumptionofvitamindfortifiedyogurtdrinkdooghimprovedendothelialbiomarkersinsubjectswithtype2diabetesarandomizeddoubleblindclinicaltrial
AT shariatzadehnastaran regularconsumptionofvitamindfortifiedyogurtdrinkdooghimprovedendothelialbiomarkersinsubjectswithtype2diabetesarandomizeddoubleblindclinicaltrial
AT zahediradmalihe regularconsumptionofvitamindfortifiedyogurtdrinkdooghimprovedendothelialbiomarkersinsubjectswithtype2diabetesarandomizeddoubleblindclinicaltrial
AT khalajiniloufar regularconsumptionofvitamindfortifiedyogurtdrinkdooghimprovedendothelialbiomarkersinsubjectswithtype2diabetesarandomizeddoubleblindclinicaltrial
AT haidarihoma regularconsumptionofvitamindfortifiedyogurtdrinkdooghimprovedendothelialbiomarkersinsubjectswithtype2diabetesarandomizeddoubleblindclinicaltrial